Endocrine therapy drugs (ETDs) play a crucial role in the treatment of hormone-sensitive cancers, such as breast, prostate, and endometrial cancers. These drugs target the hormonal pathways that fuel cancer growth and proliferation, offering a valuable treatment option for patients with hormone receptor-positive tumors. This article provides a comprehensive guide to endocrine therapy drugs, their mechanisms of action, clinical applications, and potential side effects.
Therapy Drugs (ETDs) Market is estimated to be valued at US$ 30434.86 Mn in 2023 and is expected to exhibit a CAGR of 5.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. ETDs are widely used to treat hormone-related cancers like breast, prostate and endometrial cancer. They help block the hormones known to fuel cancer cell growth. Some common ETDs include tamoxifen, letrozole, anastrozole and exemestane. These ... Read more
Endocrine therapy drugs have emerged as an important treatment option for several cancers that are hormone-sensitive, such as breast cancer, prostate cancer and more. These drugs work by blocking the effects of hormones like estrogen and progesterone in the body. Used alone or in combination with other therapies like chemotherapy or radiation, endocrine therapy drugs are helping many patients effectively manage their cancer.
